NPPB and congestive heart failure: A sub-analysis of the TIME-CHF trial (Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure) compared a symptom-guided versus an NT-proBNP-guided therapy, revealing that the latter tended to worsen primary outcomes at 18 months [51].